PWMG
ABMD

Prestige Wealth Management Group’s Abiomed Inc ABMD Stock Holding History

Prestige Wealth Management Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13
Closed -$3K – 1194
2022
Q3 		$3K Hold
13
– – ﹤0.01% 702
2022
Q2 		$3K Buy
+13
New +$3.51K ﹤0.01% 718
2020
Q2 		– Sell
-106
Closed -$15K – 982
2020
Q1 		$15K Sell
106
-708
-87% -$118K 0.01% 328
2019
Q4 		$139K Sell
814
-75
-8% -$13.9K 0.08% 140
2019
Q3 		$158K Sell
889
-40
-4% -$8.65K 0.09% 124
2019
Q2 		$242K Sell
929
-238
-20% -$63.1K 0.15% 101
2019
Q1 		$334K Buy
1,167
+8
+0.7% +$2.66K 0.21% 89
2018
Q4 		$377K Buy
+1,159
New +$403K 0.28% 67

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prestige Wealth Management Group's ABMD Position: Q4 2022 in Review

Prestige Wealth Management Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 13 shares — an estimated $3K sold.

Prestige Wealth Management Group first reported a position in ABMD in Q4 2018 and held it in 8 quarters. The position peaked at $377K in Q4 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Prestige Wealth Management Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Prestige Wealth Management Group sold 13 Abiomed Inc shares in Q4 2022, an estimated $3K.
  • Prestige Wealth Management Group first reported a position in Abiomed Inc in Q4 2018 and held it in 8 quarters.
  • Prestige Wealth Management Group's Abiomed Inc position peaked at $377K in Q4 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Prestige Wealth Management Group's 13F filing for Q4 2022, filed 8 Feb 2023.